Results 11 to 20 of about 8,421 (225)

Non-Vitamin K Antagonist Oral Anticoagulants in Differentiated Approach to the Use in Cardiological Practice: Literature Review

open access: yesУкраїнський журнал серцево-судинної хірургії, 2023
Non-vitamin K antagonist oral anticoagulants (novel oral anticoagulants, NOACs) are important pharmaceuticals for prevention of stroke and systemic embolism in non-valvular atrial fibrillation patients.
Larysa A. Vozniuk   +2 more
doaj   +1 more source

Management of haemorrhage in patients receiving non-vitamin-k oral anticoagulants treatment: Case report [PDF]

open access: yesABC: časopis urgentne medicine, 2022
Introduction: Management of haemorrhage depends on the severity of bleeding and associated injuries. In this paper, we present a case of bleeding patient on the anticoagulants for which there was no specific reversal agent. Aim of the study is to present
Rangelov-Kulezić Jasmina   +3 more
doaj   +1 more source

Treatment of Permethrin Toxicosis in Cats by Intravenous Lipid Emulsion

open access: yesToxics, 2022
Background: In this study, the clinical response to treatment with intravenous lipid emulsion (ILE) for nine cats intoxicated with permethrin has been described.
Simona Di Pietro   +5 more
doaj   +1 more source

Synthetic Amphoteric Cryogels as an Antidote against Acute Heavy Metal Poisoning

open access: yesMolecules, 2021
The effectiveness of an amphoteric cryogel (AAC) as an oral sorbent (enerosorbent) for the treatment of acute poisoning of small animals (rats) with heavy metals (HMs) was studied in in vivo experiments.
Alzhan Z. Baimenov   +6 more
doaj   +1 more source

Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Thrombolytic Therapy

open access: yesMedicina, 2022
Background and Objectives: Thrombolytic therapy with recombinant tissue-type plasminogen activator (rt-PA) is used to treat acute ischemic stroke. Dabigatran is a reversible thrombin inhibitor approved for stroke prevention in patients with nonvalvular ...
Ilga Kikule   +3 more
doaj   +1 more source

Anticoagulants: dose control methods and inhibitors

open access: yesАкушерство, гинекология и репродукция, 2022
These days, anticoagulants are in great demand. They are used as a prophylaxis for thromboembolic complications in various diseases and conditions in general therapeutic practice, cardiology, neurology, as well as obstetrics to manage high-risk ...
V. O. Bitsadze   +9 more
doaj   +1 more source

Optimization of a nicotine degrading enzyme for potential use in treatment of nicotine addiction

open access: yesBMC Biotechnology, 2019
Background Smoking and tobacco use continue to be the largest preventable causes of death globally. A novel therapeutic approach has recently been proposed: administration of an enzyme that degrades nicotine, the main addictive component of tobacco ...
Thomas Thisted   +9 more
doaj   +1 more source

The nicotine-degrading enzyme NicA2 reduces nicotine levels in blood, nicotine distribution to brain, and nicotine discrimination and reinforcement in rats

open access: yesBMC Biotechnology, 2018
Background The bacterial nicotine-degrading enzyme NicA2 isolated from P. putida was studied to assess its potential use in the treatment of tobacco dependence. Results Rats were pretreated with varying i.v.
Paul R. Pentel   +6 more
doaj   +1 more source

Protective effects and therapeutic applications of ellagic acid against natural and synthetic toxicants: A review article [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2022
Traditional herbal drugs are widely used for the treatment of various diseases. Ellagic acid (EA) as an herbal polyphenol metabolite exists in many medicinal plants.
Karim Naraki   +2 more
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy